Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases—2nd Edition
Funding
Conflicts of Interest
References
- Ferretti, G.; Bacchetti, T.; Nègre-Salvayre, A.; Salvayre, R.; Dousset, N.; Curatola, G. Structural Modifications of HDL and Functional Consequences. Atherosclerosis 2006, 184, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Zimetti, F.; Adorni, M.P.; Marsillach, J.; Marchi, C.; Trentini, A.; Valacchi, G.; Cervellati, C. Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer’s Disease: A Narrative Review. Oxid. Med. Cell. Longev. 2021, 2021, 6695796. [Google Scholar] [CrossRef] [PubMed]
- Rosenson, R.S.; Brewer, H.B.; Ansell, B.J.; Barter, P.; Chapman, M.J.; Heinecke, J.W.; Kontush, A.; Tall, A.R.; Webb, N.R. Dysfunctional HDL and Atherosclerotic Cardiovascular Disease. Nat. Rev. Cardiol. 2016, 13, 48–60. [Google Scholar] [CrossRef] [PubMed]
- Ong, K.-L.; Cochran, B.J.; Manandhar, B.; Thomas, S.; Rye, K.-A. HDL Maturation and Remodelling. Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids 2022, 1867, 159119. [Google Scholar] [CrossRef] [PubMed]
- Stadler, J.T.; Borenich, A.; Pammer, A.; Emrich, I.E.; Habisch, H.; Madl, T.; Heine, G.H.; Marsche, G. Association of Small HDL Subclasses with Mortality Risk in Chronic Kidney Disease. Antioxidants 2024, 13, 1511. [Google Scholar] [CrossRef] [PubMed]
- van der Vorst, E.P.C. High-Density Lipoproteins and Apolipoprotein A1; Springer International Publishing: Cham, Switzerland, 2020; Volume 94, ISBN 9783030417697. [Google Scholar]
- Cochran, B.J.; Ong, K.-L.; Manandhar, B.; Rye, K.-A. APOA1: A Protein with Multiple Therapeutic Functions. Curr. Atheroscler. Rep. 2021, 23, 11. [Google Scholar] [CrossRef] [PubMed]
- Cho, K.-H.; Lee, Y.; Lee, S.H.; Kim, J.-E.; Bahuguna, A.; Dominguez-Horta, M.d.C.; Martinez-Donato, G. Enhancing Wound Healing and Anti-Inflammatory Effects by Combination of CIGB-258 and Apolipoprotein A-I against Carboxymethyllysine Toxicity in Zebrafish: Insights into Structural Stabilization and Antioxidant Properties. Antioxidants 2024, 13, 1049. [Google Scholar] [CrossRef] [PubMed]
- Varlibas, F.; Akhan, O.; Can, M.; Yuksel, G.; Gul, Z. Serum HDL Associated Antioxidant Activity in Alzheimer’s Disease: Paraoxonase1 and Dysfunctional HDL. Clin. Lab. 2020, 66, 1859–1865. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.; Wu, Z.; Riwanto, M.; Gao, S.; Levison, B.S.; Gu, X.; Fu, X.; Wagner, M.A.; Besler, C.; Gerstenecker, G.; et al. Myeloperoxidase, Paraoxonase-1, and HDL Form a Functional Ternary Complex. J. Clin. Investig. 2013, 123, 3815–3828. [Google Scholar] [CrossRef] [PubMed]
- Lu, C.; Gao, Y.; Zhou, H.; Tian, H. The Relationships between PON1 Activity as Well as OxLDL Levels and Coronary Artery Lesions in CHD Patients with Diabetes Mellitus or Impaired Fasting Glucose. Coron. Artery Dis. 2008, 19, 565–573. [Google Scholar] [CrossRef] [PubMed]
- Wamique, M.; Ali, W.; Himanshu, D. Association of SRB1 and PON1 Gene Polymorphisms with Type 2 Diabetes Mellitus: A Case Control Study. Int. J. Diabetes Dev. Ctries. 2020, 40, 209–215. [Google Scholar] [CrossRef]
- Cervellati, C.; Vigna, G.B.; Trentini, A.; Sanz, J.M.; Zimetti, F.; Dalla Nora, E.; Morieri, M.L.; Zuliani, G.; Passaro, A. Paraoxonase-1 Activities in Individuals with Different HDL Circulating Levels: Implication in Reverse Cholesterol Transport and Early Vascular Damage. Atherosclerosis 2019, 285, 64–70. [Google Scholar] [CrossRef] [PubMed]
- Denimal, D. Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes. Antioxidants 2023, 13, 57. [Google Scholar] [CrossRef] [PubMed]
- Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: The Link between Insulin Resistance, Obesity and Diabetes. Trends Immunol. 2004, 25, 4–7. [Google Scholar] [CrossRef] [PubMed]
- Castañé, H.; Jiménez-Franco, A.; Martínez-Navidad, C.; Placed-Gallego, C.; Cambra-Cortés, V.; Perta, A.-M.; París, M.; Castillo, D.d.; Arenas, M.; Camps, J.; et al. Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis. Antioxidants 2023, 12, 2038. [Google Scholar] [CrossRef] [PubMed]
- Cervellati, C.; Bonaccorsi, G.; Trentini, A.; Valacchi, G.; Sanz, J.M.; Squerzanti, M.; Spagnolo, M.; Massari, L.; Crivellari, I.; Greco, P.; et al. Paraoxonase, Arylesterase and Lactonase Activities of Paraoxonase-1 (PON1) in Obese and Severely Obese Women. Scand. J. Clin. Lab. Investig. 2018, 78, 18–24. [Google Scholar] [CrossRef] [PubMed]
- Younis, A. Paraoxonase-1 Enzyme Activity Assay for Clinical Samples: Validation and Correlation Studies. Med. Sci. Monit. 2015, 21, 902–908. [Google Scholar] [CrossRef] [PubMed]
- Stankovic, M.; Zeljkovic, A.; Vekic, J.; Antonic, T.; Ardalic, D.; Miljkovic-Trailovic, M.; Munjas, J.; Saric Matutinovic, M.; Gojkovic, T.; Jovicic, S.; et al. Differences in HDL Remodeling during Healthy Pregnancy and Pregnancy with Cardiometabolic Complications. Antioxidants 2024, 13, 948. [Google Scholar] [CrossRef] [PubMed]
- Trentini, A.; Rosta, V.; Riccetti, R.; Mola, G.; Galletti, R.; Pinotti, M.; Senia, V.; Zuliani, G.; Cervellati, C. PON1 and PON3 in Alzheimer’s Disease: Similar Functions but Different Roles. Antioxidants 2024, 13, 1216. [Google Scholar] [CrossRef]
- Cho, K.-H.; Kim, J.-E.; Lee, M.-S.; Bahuguna, A. Oral Supplementation of Ozonated Sunflower Oil Augments Plasma Antioxidant and Anti-Inflammatory Abilities with Enhancement of High-Density Lipoproteins Functionality in Rats. Antioxidants 2024, 13, 529. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cervellati, C.; Marsillach, J. Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases—2nd Edition. Antioxidants 2025, 14, 358. https://doi.org/10.3390/antiox14030358
Cervellati C, Marsillach J. Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases—2nd Edition. Antioxidants. 2025; 14(3):358. https://doi.org/10.3390/antiox14030358
Chicago/Turabian StyleCervellati, Carlo, and Judit Marsillach. 2025. "Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases—2nd Edition" Antioxidants 14, no. 3: 358. https://doi.org/10.3390/antiox14030358
APA StyleCervellati, C., & Marsillach, J. (2025). Impact of Antioxidant and Anti-Inflammatory Functions of HDL in Diseases—2nd Edition. Antioxidants, 14(3), 358. https://doi.org/10.3390/antiox14030358